Kintara Therapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Academic Collaborations
    • Advisors
  • Pipeline
    • Overview
    • VAL-083
    • REM-001
  • Clinical Trials
  • News & Media
    • Press Releases
    • Publications and Abstracts
    • Presentations
    • Recent News
    • Events
  • Investors
    • Overview
    • Analyst Coverage
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications and Abstracts
  • Presentations
  • Recent News
  • Events

Kintara Therapeutics to Present at the H.C. Wainwright Bioconnect 2022 Virtual Conference

Jan 5, 2022

Kintara Therapeutics to Present at the MedInvest Oncology Investor Conference on December 9, 2021

Dec 7, 2021

Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma

Nov 30, 2021

Kintara Presents Updates on Two Phase 2 Clinical Studies at the 2021 Society for Neuro-oncology Annual Meeting

Nov 18, 2021

Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results and Provides Corporate Update

Nov 15, 2021

Kintara Therapeutics to Present at the Q4 Investor Summit Virtual Conference on November 17, 2021

Nov 11, 2021

Kintara Announces Changes to Executive Leadership Team

Nov 9, 2021

Kintara Therapeutics to Present at the LD Micro Main Event Conference

Oct 11, 2021

Kintara Therapeutics Announces Fiscal Year 2021 Financial Results and Provides Corporate Update

Sep 29, 2021

Kintara Announces Closing of $15.0 million Offering Priced at a Premium to Market

Sep 28, 2021
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...33
    © 2023 Kintara Therapeutics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap Legal Information Manage Cookie Preferences